Update information. Schizophrenia has a high rate of misdiagnosis, leading to inappropriate or delayed treatment. Combining with extracellular vesicles’ (EVs) proteome profiling and XGBoost-based machine learning, we developed new pan-EVs markers and yielded personalized discrimination scores (PDS) for schizophrenia diagnosis, subtyping and predicting treatment response.